A meta‐analysis of andexanet alfa and prothrombin complex concentrate in the treatment of factor Xa inhibitor–related major bleeding

por Jaspers, Tessa, Shudofsky, Kimberly, Huisman, Menno V., Meijer, Karina, Khorsand, Nakisa
Publicado 2021

Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis

por Abdoellakhan, Rahat Amadkhan, Miah, Ishita Parveen, Khorsand, Nakisa, Meijer, Karina, Jellema, Korné
Publicado 2016

Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleeding

por Abdoellakhan, Rahat A., Beyer‐Westendorf, Jan, Schulman, Sam, Sarode, Ravi, Meijer, Karina, Khorsand, Nakisa
Publicado 2019

Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3)

por Abdoellakhan, Rahat A, Khorsand, Nakisa, Van Hest, Reinier M, Veeger, Nic, Ter Avest, Ewoud, Ypma, Paula F, Faber, Laura M, Meijer, Karina
Publicado 2018

Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels

por Jaspers, Tessa C. C., Meijer, Charlotte E., Vleming, Louis Jean, Franssen, Casper F. M., Diepstraten, Jeroen, Lukens, Michael V., van den Bemt, Patricia M. L. A., Maat, Barbara, Khorsand, Nakisa, Touw, Daniël J., Koomen, Jeroen V.
Publicado 2022